Literature DB >> 22447860

A comparison of HLA genotype with inflammation in uveal melanoma.

T Huibertus van Essen1, Inge H G Bronkhorst, Willem Maat, Willem Verduyn, Dave L Roelen, Gregorius P M Luyten, Martine J Jager.   

Abstract

PURPOSE: Human leukocyte antigen (HLA) polymorphisms have been associated with the development of autoimmune diseases. In uveal melanoma, a high expression of HLA classes I and II, and infiltration with lymphocytes and macrophages are associated with a bad prognosis. Inflammation has an important role in this malignancy. The goal of our study was to determine whether specific HLA alleles are associated with increased inflammation.
METHODS: Records were analyzed of 45 patients who underwent enucleation for uveal melanoma. HLA typing, tumor HLA expression and tumor macrophage infiltration were determined in each case.
RESULTS: Before correction for multiple testing, macrophage infiltration was less in HLA-A2 positive patients. Patients with HLA-DR6 had a higher tumor cell expression of HLA-DR. After correction for the number of analyses, no associations remained statistically significant.
CONCLUSION: The results before correction suggest that the HLA genotype may influence inflammation as indicated by HLA expression and macrophage infiltration in uveal melanoma. However, after correction this association did not prove significant.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22447860     DOI: 10.1167/iovs.11-8901

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  4 in total

1.  Upregulation of HLA Expression in Primary Uveal Melanoma by Infiltrating Leukocytes.

Authors:  T Huibertus van Essen; Sake I van Pelt; Inge H G Bronkhorst; Mieke Versluis; Fariba Némati; Cécile Laurent; Gregorius P M Luyten; Thorbald van Hall; Peter J van den Elsen; Pieter A van der Velden; Didier Decaudin; Martine J Jager
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

Review 2.  HLA Expression in Uveal Melanoma: An Indicator of Malignancy and a Modifiable Immunological Target.

Authors:  Zahra Souri; Annemijn P A Wierenga; Arend Mulder; Aart G Jochemsen; Martine J Jager
Journal:  Cancers (Basel)       Date:  2019-08-07       Impact factor: 6.639

3.  HLA-A2 Promotes the Therapeutic Effect of Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Hyperoxic Lung Injury.

Authors:  Jihye Kwak; Wankyu Choi; Yunkyung Bae; Miyeon Kim; Soojin Choi; Wonil Oh; Hyejin Jin
Journal:  Bioengineering (Basel)       Date:  2022-04-18

4.  Therapeutic applications of the selective high affinity ligand drug SH7139 extend beyond non-Hodgkin's lymphoma to many other types of solid cancers.

Authors:  Rod Balhorn; Monique Cosman Balhorn
Journal:  Oncotarget       Date:  2020-09-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.